Home›Compare›MangoRx vs Wisp

MangoRx vs Wisp: Which Is Better?

Head-to-head comparison of MangoRx and Wisp based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Wisp scores higher overall in our independent evaluation (73.6/100 vs 58/100), leading on trust & safety, value, experience, product range, reputation.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
74
Wisp
Good

Async telehealth platform for sexual and reproductive health, prescribing UTI, BV, yeast, herpes, STI, birth control, and menopause treatment at scale with no consult fee.

Visit Wisp

Score Breakdown

DimensionMangoRxWisp
Overall Score58/10073.6/100 ✓
Trust & Safety30%55/10072/100 ✓
Value25%62/10078/100 ✓
Experience20%58/10070/100 ✓
Product Range15%66/10075/100 ✓
Reputation10%45/10072/100 ✓

At a Glance

Founded20212018
HeadquartersDallas, TXAustin, TX
Publicly tradedYes (MGRX)No
Treatment categories54
Treatments listed54
Starting price$50/mo$5/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxWisp
Sexual Health$59–$75
Mango ED (sildenafil or tadalafil)
$40–$70
Herpes / Cold Sore Antiviral Treatment
Weight Loss / GLP-1$299
Slim (compounded oral semaglutide ODT)
—

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Wisp

+No consult fee, with async intake and prescriptions typically issued within hours
+Broad service line under one account: UTI, BV, yeast, herpes, STI treatment/prevention (including DoxyPEP), birth control, and menopause care
+Large scale and review base (2M+ patients, 11,496 Trustpilot reviews at 4.1) indicating consistent service delivery
−Recurring reports of patients being charged for prescriptions that were never sent to the pharmacy, paired with difficulty reaching phone support
−Some patients report side effects or mismatched treatment, suggesting async intake screening can miss individual nuance a live visit would catch
−Weight-care and membership pricing are not fully published prior to starting an intake
Read the full Wisp review →

MangoRx vs Wisp — FAQ

Is MangoRx better than Wisp?

▾

Wisp scores higher overall in our independent evaluation (73.6/100 vs 58/100), leading on trust & safety, value, experience, product range, reputation.

Is MangoRx or Wisp cheaper?

▾

Wisp has the lower starting price (from $5/mo vs $50/mo for MangoRx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and Wisp both offer?

▾

Both platforms treat Sexual Health, Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and Wisp covers 4.

Still deciding?